# Shi Zhengzheng

> Shi Zhengzheng is a seed investor at Yingke Capital (Fuzhou) backing Biotechnology and Genetics. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Yingke Capital](https://shizune.co/investors/profile/yingke-capital)
- Location: Fuzhou, China
- Total investments: 2
- Last investment: Mar 2022
- Lead investor: 50%
- Last updated: Aug 2026

Shi Zhengzheng is a seed investor at Yingke Capital in Fuzhou focused on Biotechnology and Genetics. Shi Zhengzheng working as a partner of Yingke Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Genetics | 1 | 50% |
| Health Care | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Gene Vector | Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | $3.2M | Seed | Mar 10, 2022 |  |
| Hrain Biotechnology | Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform. |  | Series C | Apr 26, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Ming capital](https://shizune.co/investors/profile/ming-capital) — VC Fund, 1 deal together
- [Ruijing Investment](https://shizune.co/investors/profile/ruijing-investment) — VC Fund, 1 deal together
- [October Capital](https://shizune.co/investors/profile/shanghai-october-asset-management) — VC Fund, 1 deal together
- [Sichuan Huisu](https://shizune.co/investors/profile/sichuan-huisu) — VC Fund, 1 deal together
- [Wuhan East Lake High Technology](https://shizune.co/investors/profile/wuhan-east-lake-high-technology) — VC Fund, 1 deal together

## About Yingke Capital

VC Fund · Fuzhou, China

Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&D and productioncapacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.

5 contacts available at Yingke Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Chen Yulei | Chief Investment Officer | https://shizune.co/investors/profile/chen-yulei-fbff |
| Manying Lai | President | https://shizune.co/investors/profile/manying-lai |
| Shi Zhengzheng | Partner | https://shizune.co/investors/profile/shi-zhengzheng |
| Shuqing Wu | President of Financial Division | https://shizune.co/investors/profile/shuqing-wu |
| Xiaochen Zhou | Vice-President | https://shizune.co/investors/profile/xiaochen-zhou |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Shi Zhengzheng invest in?

Shi Zhengzheng invests primarily in Biotechnology, Genetics and Health Care startups, most often at Seed and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shi Zhengzheng last invest?

The most recent investment recorded for Shi Zhengzheng closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co